EUVIMEDEUVIMED entdecken
Crossref

Effective Usage of Semaglutide from the Point of View of Body Weight Reduction: Significance of Combination Therapy with SGLT2 inhibitor and/or Metformin

Yutaka Mori

Diabetes Frontier Online · 16.12.2025 · 12 (e1) · 001-001

DOI: 10.15634/j0100_1201_006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Frontier Online, erschienen am 16.12.2025. Verfasst von Yutaka Mori.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mori, Y. (2025). Effective Usage of Semaglutide from the Point of View of Body Weight Reduction: Significance of Combination Therapy with SGLT2 inhibitor and/or Metformin. Diabetes Frontier Online, 12(e1), 001-001. https://doi.org/10.15634/j0100_1201_006

Vancouver

Mori Y. Effective Usage of Semaglutide from the Point of View of Body Weight Reduction: Significance of Combination Therapy with SGLT2 inhibitor and/or Metformin. Diabetes Frontier Online. 2025;12(e1):001-001. doi:10.15634/j0100_1201_006

BibTeX
@article{Mori2025,
  author = {Mori, Yutaka},
  title = {Effective Usage of Semaglutide from the Point of View of Body Weight Reduction: Significance of Combination Therapy with SGLT2 inhibitor and/or Metformin},
  journal = {Diabetes Frontier Online},
  year = {2025},
  volume = {12},
  number = {e1},
  pages = {001--001},
  doi = {10.15634/j0100_1201_006}
}
Kostenlos starten →